EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Oral Versus Intravenous Antibiotic Therapy for Staphylococcus aureus Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials

Ahmad Mourad iD, Nnamdi Nwafo, Lesley Skalla, Thomas L Holland, Timothy C Jenkins

Clinical Infectious Diseases · 05.02.2025 · 80 (1) · 29-36

DOI: 10.1093/cid/ciae476 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 18.09.2024. Verfasst von Ahmad Mourad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Bacteremia, Anti-Bacterial Agents, Staphylococcal Infections, Endocarditis, Bacterial. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We conducted a systematic review of randomized, controlled trials (RCTs) to generate more precise estimates of the efficacy and safety of oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis.

Methods

MEDLINE, Embase, the Cochrane Library, and Web of Science databases were searched through February 2024. RCTs were included if they compared oral versus intravenous antibiotic therapy for S. aureus bacteremia or endocarditis and appropriately reported outcomes for each group. Risk of bias was assessed using the revised Cochrane tool for assessing risk of bias in randomized trials. Heterogeneity between studies was evaluated with Cochran's Q-statistic and I2 test. Treatment effects were summarized with pooled risk ratios using a random effects model meta-analysis (PROSPERO CRD42024481512).

Results

Only four RCTs met criteria for inclusion in meta-analysis. Among participants assessed for treatment failure, there was no difference between oral and intravenous therapy groups (risk ratio [RR], 0.99; 95% confidence interval [CI], .63–1.57; I2 = 0%). There was also no significant difference in adverse events between oral and intravenous therapy groups (RR, 0.65; 95% CI, .07–5.94; I2 = 74%); however, the confidence interval was wide, and heterogeneity was high.

Conclusions

In this systematic review of RCTs comparing oral with intravenous antibiotic therapy for S. aureus bacteremia or endocarditis, few studies met the eligibility criteria for inclusion. Meta-analysis of these studies suggests that transitioning from intravenous to oral therapy is likely effective in a subgroup of carefully selected patients. Additional randomized trials are necessary before transition to oral therapy can be routinely recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaAnti-Bacterial AgentsStaphylococcal InfectionsEndocarditis, BacterialStaphylococcus aureusHumansAdministration, OralRandomized Controlled Trials as TopicAdministration, IntravenousTreatment Outcome

Stichwörter der Autor:innen

Staphylococcus aureus bacteremiaendocarditisoral antibiotic therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
  • Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Department of Medicine, Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Duke University Medical Center Library & Archives, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Medicine, Division of Infectious Diseases, Denver Health, Denver, Colorado, USA.
  • Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA.

ORCID-Profile: Ahmad Mourad

Zitieren

APA

Mourad, A., Nwafo, N., Skalla, L., Holland, T. L., & Jenkins, T. C. (2025). Oral Versus Intravenous Antibiotic Therapy for Staphylococcus aureus Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Clinical Infectious Diseases, 80(1), 29-36. https://doi.org/10.1093/cid/ciae476

Vancouver

Mourad A, Nwafo N, Skalla L, Holland TL, Jenkins TC. Oral Versus Intravenous Antibiotic Therapy for Staphylococcus aureus Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Clinical Infectious Diseases. 2025;80(1):29-36. doi:10.1093/cid/ciae476

BibTeX
@article{Mourad2025,
  author = {Mourad, Ahmad and Nwafo, Nnamdi and Skalla, Lesley and Holland, Thomas L and Jenkins, Timothy C},
  title = {Oral Versus Intravenous Antibiotic Therapy for Staphylococcus aureus Bacteremia or Endocarditis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  volume = {80},
  number = {1},
  pages = {29--36},
  doi = {10.1093/cid/ciae476}
}
Kostenlos starten →